| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |